Skip to main content
Clinical Trials/NCT04990401
NCT04990401
Completed
Not Applicable

Adapted Tele-Behavioral Activation Targeted to Increase Physical Activity in Depression

University of Texas Southwestern Medical Center1 site in 1 country65 target enrollmentAugust 31, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
University of Texas Southwestern Medical Center
Enrollment
65
Locations
1
Primary Endpoint
Feasibility and acceptability - Screening
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This is a pilot study of acceptability, feasibility, and preliminary efficacy of a brief, 10-session Behavioral Activation intervention delivered via teletherapy to increase physical activity and treat depressive symptoms.

Detailed Description

This is a one-site, two-phase study that will use an initial group of individuals between the ages of 18 and 64 who have moderate to severe depressive symptoms and exercise less than 90 minutes a week. In both phases, participants will complete a total of 8 behavioral activation teletherapy sessions used to increase physical activity, followed by two biweekly booster sessions, for a total of 10 sessions. Participants will also complete weekly assessments remotely for both phases of the study. The screening visit and final intervention session will be in-person, and all other visits will be via telehealth. Participants will have the option to come to the clinic if they prefer. In the initial phase (n = 15), participants who completed the intervention will have the option to participate in a focus group, and participants who partially completed the intervention will have the option to participate in a semi-structured interview. The total duration of phase one is 14 weeks. This initial phase will allow the researchers to refine and optimize the intervention to be delivered in the second phase. In the second/pilot phase (n = 50), participants will complete a one-month and a two-month follow-up after the 10 intervention sessions. The total duration for phase two is 22 weeks. Participants for both phases of the study will wear a Fitbit during the duration of their study participation, in order to record step count.

Registry
clinicaltrials.gov
Start Date
August 31, 2021
End Date
May 31, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Madhukar H. Trivedi, MD

Professor of Medicine

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Be18-64 years old;
  • Able and willing to provide informed consent;
  • Have moderate-to-severe depressive symptoms, with a PHQ-9 score ≥ 10;
  • Insufficient moderate-to-vigorous physical activity (\< 90 minutes a week);
  • Demonstrated interest in increasing physical activity;
  • Have a smartphone.

Exclusion Criteria

  • Have any current, past, or lifetime manic or hypomanic episode, psychosis, schizophrenia or schizophreniform disorder;
  • Be currently experiencing active suicidal ideation (i.e. with suicidal thoughts, plan, and intent) or at a high risk for suicide during the course of the study, as designated by the PI;
  • Have a medical condition that prohibits physical activity; be medically prohibited to exercise by primary care physician (PCP), OB-GYN (obstetrician-gynecologist) or study MD.
  • Be in current, active psychotherapy

Outcomes

Primary Outcomes

Feasibility and acceptability - Screening

Time Frame: 1 week

Number of participants screened per week (Goal 1-2 per week)

Intervention Adherence

Time Frame: Up to 14 weeks

Percentage of intervention sessions attended (goal 75%)

Participant retention

Time Frame: Up to 22 weeks

Percentage of PHQ-9 assessments completed (Goal: 80%)

Participant outcome completion

Time Frame: Up to 22 weeks

Percentage of valid Fitbit wear days \> 12 hours (Goal: 80%)

Feasibility and acceptability - Recruitment

Time Frame: 1 week

Percentage of screened participants enrolled (Goal: 50%)

Intervention Validity via Quality of Behavioral Activation Short Form

Time Frame: Up to 14 weeks

Fidelity on supervisor's structured feedback form with average item score ≥3. The 14-item scale has each item ranging from 0-6, with higher values indicating higher levels of fidelity.

Secondary Outcomes

  • Physical activity - self-report days per week(Up to 22 weeks)
  • Physical activity - Fitbit step counter active minutes(Up to 22 weeks)
  • Physical activity - self-report minutes per day(Up to 22 weeks)
  • Physical activity - Fitbit step counter step count(Up to 22 weeks)
  • Depressive symptoms - 9-item Patient Health Questionnaire(Up to 22 weeks)

Study Sites (1)

Loading locations...

Similar Trials